Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives

Excessive sleepiness (ES) is a symptom of obstructive sleep apnea (OSA) and narcolepsy that has severe consequences. Wake-promoting drugs and stimulants are utilized as accessory treatment in OSA to reduce propensity to sleep but they do not improve sleep-disordered breathing. Solriamfetol is a firs...

Descripción completa

Detalles Bibliográficos
Autor principal: Abad, Vivien C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846869/
https://www.ncbi.nlm.nih.gov/pubmed/33531850
http://dx.doi.org/10.2147/NSS.S245020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846869/
https://www.ncbi.nlm.nih.gov/pubmed/33531850
http://dx.doi.org/10.2147/NSS.S245020

Ejemplares similares